Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Nature's Pharmacy & Compounding Center
483
•Nature's Pharmacy & Compounding Center•November 22, 2013

Nature's Pharmacy & Compounding Center – FDA 483, Nov 22, 2013

Record Details

During an FDA inspection conducted from November 12-22, 2013, Nature's Pharmacy & Compounding Center, a producer of sterile drugs, received a Form FDA 483 citing numerous significant deficiencies. The observations primarily highlighted critical failures in quality control and aseptic processing, indicating a lack of adherence to manufacturing standards. Key violations included the absence of essential laboratory controls; specifically, the firm failed to perform assay, sterility, or endotoxin testing on any of the sterile injectable or ophthalmic drug products it manufactured and distributed. Furthermore, the sterilization processes used were not validated, with no media fills or process simulations ever conducted. The facility also exhibited severe shortcomings in its environmental monitoring program, lacking microbial air, surface, and personnel monitoring, and failing to verify aseptic area air supply through smoke studies or continuous pressure monitoring. Additional issues involved inadequate cleaning and disinfection practices, the use of inappropriate non-sterile garments by personnel during aseptic operations, and a complete absence of a written program for stability testing to support product expiration dates. Crucially, the firm lacked established written procedures for its quality control unit, encompassing sterile drug processing, testing, and quality assurance. These observations collectively require the company to implement comprehensive corrective actions to ensure the safety, quality, and purity of its sterile drug products.

Company
Nature's Pharmacy & Compounding Center
Inspection date
November 22, 2013
Product type
Drugs
Office
Atlanta District Office
Person
  • Bonita S. Chester (Director of Inspection Readiness)
View Company Profile

ID · 81e5a740-e50e-4650-b3e4-c6cdebaabc0e

Violation Codes2
21 CFR 21021 CFR 211

Full citation text and observation details available on the Dashboard.

Other documents for Nature's Pharmacy & Compounding Center
  • WARNING_LETTER - 2013-11-22November 22, 2013

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Nature's Pharmacy & Compounding Center
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.